EP0935654A4 - Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use - Google Patents

Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use

Info

Publication number
EP0935654A4
EP0935654A4 EP97916166A EP97916166A EP0935654A4 EP 0935654 A4 EP0935654 A4 EP 0935654A4 EP 97916166 A EP97916166 A EP 97916166A EP 97916166 A EP97916166 A EP 97916166A EP 0935654 A4 EP0935654 A4 EP 0935654A4
Authority
EP
European Patent Office
Prior art keywords
fhf
methods
factor
fibroblast growth
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP97916166A
Other languages
German (de)
French (fr)
Other versions
EP0935654A1 (en
Inventor
Jeremy Nathans
Philip M Smallwood
Patrick Tong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
School of Medicine of Johns Hopkins University
Original Assignee
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Johns Hopkins University
Publication of EP0935654A1 publication Critical patent/EP0935654A1/en
Publication of EP0935654A4 publication Critical patent/EP0935654A4/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP97916166A 1996-03-21 1997-03-21 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use Ceased EP0935654A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US621143 1990-12-03
US62114396A 1996-03-21 1996-03-21
PCT/US1997/004641 WO1997035007A1 (en) 1996-03-21 1997-03-21 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use

Publications (2)

Publication Number Publication Date
EP0935654A1 EP0935654A1 (en) 1999-08-18
EP0935654A4 true EP0935654A4 (en) 2000-07-05

Family

ID=24488909

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97916166A Ceased EP0935654A4 (en) 1996-03-21 1997-03-21 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use

Country Status (6)

Country Link
EP (1) EP0935654A4 (en)
JP (1) JP2000509965A (en)
AU (1) AU719538B2 (en)
CA (1) CA2249179A1 (en)
IL (1) IL126298A0 (en)
WO (1) WO1997035007A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US5693775A (en) * 1995-05-12 1997-12-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
US5876967A (en) * 1995-05-12 1999-03-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-2 and methods of use
US6110893A (en) * 1995-06-05 2000-08-29 Human Genome Sciences, Inc. Fibroblast growth factor 11
US6605441B1 (en) 1995-06-05 2003-08-12 Human Genome Sciences, Inc. Antibodies against fibroblast growth factor 11
US6787640B2 (en) 1995-06-05 2004-09-07 Human Genome Sciences, Inc. Fibroblast growth factor 14
US6020189A (en) * 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
CN112625140A (en) * 2020-12-22 2021-04-09 北京致力生科科技有限公司 PEP-1-G4S-KGF2 fusion protein and coding gene and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039506A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Fibroblast growth factor-14
WO1998008864A1 (en) * 1996-08-30 1998-03-05 The Johns Hopkins University School Of Medicine FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039509A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Fibroblast growth factor 15

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039506A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Fibroblast growth factor-14
WO1998008864A1 (en) * 1996-08-30 1998-03-05 The Johns Hopkins University School Of Medicine FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRODY L ET AL: "Construction of Transcription Map Surrounding the BRCA1 Locus of Human Chromosome 17", GENOMICS, vol. 25, no. 1, 1 January 1995 (1995-01-01), pages 238 - 247, XP002093717, ISSN: 0888-7543 *
BRODY L. C. ET AL.: "Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17; MTO120 Homo sapiens genomic clone MTO120", EMBL DATABASE ENTRY HS21510; ACCESSION NO. T27215, 31 December 1994 (1994-12-31), XP002134210 *
HILLIER L. ET AL.: "The WashU-Merck EST Project; ym27b06.r1 Homo sapiens cDNA clone 49284 5' similar to SP:FGF9_HUMAN P31371 GLIA-ACTIVATING FACTOR PRECURSOR", EMBL DATABASE ENTRY HS590166; ACCESSION NO. H15590, 3 July 1995 (1995-07-03), XP002134209 *
See also references of WO9735007A1 *

Also Published As

Publication number Publication date
JP2000509965A (en) 2000-08-08
AU2341597A (en) 1997-10-10
EP0935654A1 (en) 1999-08-18
CA2249179A1 (en) 1997-09-25
IL126298A0 (en) 1999-05-09
AU719538B2 (en) 2000-05-11
WO1997035007A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
EP0880356A4 (en) Antimicrobial peptides and methods of use
IL126891A0 (en) Reparation and prevention of fibrotic lesions
AU7714898A (en) Bone morphogenetic proteins and their use in bone growth
EP0527781A4 (en) Methods and formulations for stabilizing fibroblast growth factor
AU1738200A (en) Tissue acquisition system and method of use
EP0929663A4 (en) Method of increasing growth and yield in plants
AU5520998A (en) Reduction of hair growth
AU3599597A (en) Reduction of hair growth
HK1039342A1 (en) Connective tissue growth factor (ctgf) and methods of use
EP0929575A4 (en) Novel human growth factors
AU5730298A (en) Reduction of hair growth
ZA919259B (en) Active fragments of fibroblast growth factor
IL126123A0 (en) Antibiotic cocktail and method of use
EP1127131A4 (en) Connective tissue growth factor (ctgf) and methods of use
AU4362696A (en) Growth inhibitory peptide and methods of using same
EP0935654A4 (en) Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
AU3170499A (en) Fibroblast growth factor mutein compositions and methods of use therefor
AU3118297A (en) Sok-1 and methods of use
EP0873360A4 (en) Transforming growth factor alpha hiii
HUP9904175A3 (en) Human growth gene and short stature gene region
AU1942995A (en) New use of growth hormone
AU7359496A (en) Methods for inhibiting cardiac fibroblast growth and cardiac fibrosis
EP0796325A4 (en) Human vascular ibp-like growth factor
AU3389197A (en) $(d)-erythroid kruppel-like factors and methods of use
AU2062497A (en) Antisense interleukin 10 and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981014

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000518

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20060415